Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.
about
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphismProthrombotic gene polymorphisms and atherothrombotic cerebral infarctionCausal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinantsGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationThe plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.Transgenic mouse models in angiogenesis and cardiovascular disease.Pleiotropic functions of plasminogen activator inhibitor-1.Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsPlasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal SepsisAcute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways.Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionGenetic background of idiopathic pulmonary fibrosis.Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins.Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity.The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women.Heritability of features of the insulin resistance syndrome in a community-based study of healthy families.The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia.Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular diseaseThe plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH StudyThe −844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis
P2860
Q24815761-8DFDFD5C-BC7C-402D-B983-A5AF479FF4BDQ28187014-1353D9E5-8436-4603-97C5-F9AEDE183065Q28472816-2D536C89-C535-4F8C-96A2-5F7C54322372Q30415902-DC1F20F6-3E1B-4521-B269-DC2641FFA00BQ31899830-3FED7774-703E-445F-85BF-8EA02BA857D4Q33843594-597852A6-41D6-420F-A921-27790E435FC3Q33984228-2BB0EDE7-399D-4620-ACBD-8B3BCD465E3FQ34133369-6CCA4A61-C085-4671-AE42-E90E974C5DB2Q34217461-23990888-2DAD-403C-A2D2-34654756F87AQ34529991-706B024F-F9F8-492C-ADCB-899E71C4A1FFQ35151527-2993FFFF-F71A-4418-9BF1-4DCCD4D4FD29Q35181647-686F767F-F676-48C9-B271-538A20C9906CQ35721055-B164809C-9BB5-47B6-BCA4-67B1FF7E6699Q36205537-73E83364-3E2D-4F52-8181-4E6F370B1F93Q36505016-4D353739-DE6F-483F-AA31-1B16D770B845Q37318149-EC57C32B-FB94-4138-BA1A-1FEC4ED74881Q38103596-1E16AD08-2CAA-4FAA-A609-8F97F171CF42Q38383836-31206E29-8C61-44C5-B22C-D71F7CBD5D6DQ38716761-C94279CC-6AFE-4383-8C33-0F689A07F46AQ39654735-66E7EB34-2868-4DE2-8565-D27B2882F2C5Q43176368-D1258978-D4EF-43CC-B718-B3A735330A29Q43255172-F0E0272E-A1F7-4D34-B329-C7A531A5A71DQ43961943-80732E38-34AD-4360-A430-A09E2A5BAB3BQ44369238-BAF3060D-F895-4C3E-A549-61F89BDC1196Q46447105-5E70D0D2-0325-43B5-86E5-11CAEAC2D8B0Q54547304-1EE878AA-2F55-4A8A-B554-47C8EABCC5E8Q54888331-962B8CF7-C46B-4989-85C2-25D64D87A3CAQ57398894-6FC88C62-D3F3-4F7B-8915-8ECE7B44A1EAQ58052205-616FA15B-A287-4BC8-B0BC-8E05623B0DB0
P2860
Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@en
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@nl
type
label
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@en
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@nl
prefLabel
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@en
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@nl
P2093
P356
P1476
Metabolic determinants are muc ...... part of the Stanislas Cohort.
@en
P2093
P356
10.1161/01.ATV.18.1.84
P407
P577
1998-01-01T00:00:00Z